Analysed TENON MEDICAL INC-28 (TNONW:NASDAQ) News Sources
Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338
11-09-2026
yahoo.com
WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338
11-09-2026
yahoo.com
Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338
14-09-2026
yahoo.com
WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338
14-09-2026
yahoo.com
Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch
30-09-2026
yahoo.com
Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026
15-10-2026
yahoo.com
Tenon Medical(R) Announces Completion of Initial Alpha Cases of the New Quickstep(TM) Decorticator for the Next-Generation SImmetry(R)+ SI Joint Fusion System
28-10-2026
yahoo.com
What is the current price of TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The current price of TENON MEDICAL INC-28 (TNONW:NASDAQ) is $0.003.
TENON MEDICAL INC-28 (TNONW:NASDAQ) absolute price change since previous trading day?
The absolute price change of TENON MEDICAL INC-28 (TNONW:NASDAQ) since the previous trading day is $-0.0017.
TENON MEDICAL INC-28 (TNONW:NASDAQ) percentage price change since previous trading day?
The percentage price change of TENON MEDICAL INC-28 (TNONW:NASDAQ) since the previous trading day is -36.1702%.
What is the most recent average sentiment score for TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The most recent average sentiment score for TENON MEDICAL INC-28 (TNONW:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The most recent sentiment for TENON MEDICAL INC-28 (TNONW:NASDAQ) is .
SEC-8K** Filing Available For TENON MEDICAL INC-28 (TNONW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.